TRICYCLIC MODULATORS OF TNF SIGNALING

The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological...

Full description

Saved in:
Bibliographic Details
Main Authors OSUMA, Augustine, BREINLINGER, Eric, C, DJURIC, Stevan, DOMBROWSKI, Amanda, W, COX, Phil, B, ROWLEY, Ann, Marie, WILSON, Noel, FRIEDMAN, Michael, M, VASUDEVAN, Anil, DAANEN, Jerome, SCHMIDT, Robert, LI, Huan-Qui, GOMTSYAN, Arthur, LONGENECKER, Kenton, DIETRICH, Justin, FRANK, Kristine, E
Format Patent
LanguageEnglish
French
German
Published 07.03.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.
Bibliography:Application Number: EP20160721023